Surgery Partners, Inc. (SGRY) FY2026 YTD Q2 P&L / Income Statement

Surgery Partners, Inc. (SGRY) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenues

1,659,800,000 US dollars

Total operating expenses

1,491,900,000 US dollars

Operating income

167,900,000 US dollars

Other income (expense), net (calculated)

negative 138,900,000 US dollars

Income (loss) before income taxes

29,000,000 US dollars

Income tax (expense) benefit

1,400,000 US dollars

Net income (loss)

27,600,000 US dollars

Private insurance

800,300,000 US dollars

Government

738,100,000 US dollars

Self-pay

42,700,000 US dollars

Other

37,100,000 US dollars

Other service revenues

41,600,000 US dollars

Net (gain) loss on disposals, consolidations and deconsolidations

6,700,000 US dollars

Salaries and benefits

500,500,000 US dollars

Supplies

447,000,000 US dollars

Professional and medical fees

204,100,000 US dollars

Other operating expenses

110,600,000 US dollars

Lease expense

47,200,000 US dollars

Transaction and integration costs

34,000,000 US dollars

Litigation settlements

2,500,000 US dollars

General and administrative expenses

75,600,000 US dollars

Other income, net

negative 3,600,000 US dollars

Depreciation and amortization

77,800,000 US dollars

Equity in earnings of unconsolidated affiliates

negative 10,500,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to Surgery Partners, Inc.: −$50.90 M; to noncontrolling interests: $78.50 M.